Sign In
Buy GILD
$125.05
+0.180 (+0.144%)
At Close: Jun 23, 2026
Diversified Trust Co Increases Holdings in Gilead Sciences, Inc. $GILD
05:42am, Tuesday, 30'th Dec 2025
Diversified Trust Co raised its holdings in shares of Gilead Sciences, Inc. (NASDAQ: GILD) by 24.2% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commi
Abacus FCF Advisors LLC Reduces Holdings in Gilead Sciences, Inc. $GILD
03:13am, Tuesday, 30'th Dec 2025
Abacus FCF Advisors LLC trimmed its position in Gilead Sciences, Inc. (NASDAQ: GILD) by 16.0% during the undefined quarter, according to the company in its most recent Form 13F filing with the Securit
Regatta Capital Group LLC Makes New Investment in Gilead Sciences, Inc. $GILD
06:24am, Monday, 29'th Dec 2025
Regatta Capital Group LLC acquired a new stake in Gilead Sciences, Inc. (NASDAQ: GILD) in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund acquired
Gilead Sciences, Inc. $GILD Shares Bought by E. Ohman J or Asset Management AB
04:43am, Sunday, 28'th Dec 2025
E. Ohman J or Asset Management AB grew its stake in Gilead Sciences, Inc. (NASDAQ: GILD) by 516.3% during the undefined quarter, according to its most recent Form 13F filing with the Securities and Ex
GILD Exercises Option to License Assembly Bio's Herpes Programs
11:45am, Tuesday, 23'rd Dec 2025
Gilead exercises its option to license ASMB's HSV programs for developing long-acting candidates, ABI-1179 & ABI-5366, for recurrent genital herpes.
Confluence Investment Management LLC Sells 16,861 Shares of Gilead Sciences, Inc. $GILD
05:20am, Tuesday, 23'rd Dec 2025
Confluence Investment Management LLC decreased its holdings in shares of Gilead Sciences, Inc. (NASDAQ: GILD) by 1.7% in the undefined quarter, according to the company in its most recent 13F filing w
Gilead Sciences to Present at Upcoming Investor Conference
04:05pm, Monday, 22'nd Dec 2025
FOSTER CITY, Calif.--(BUSINESS WIRE)-- #GILD--Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its executives will be speaking at the following investor conference: J.P. Morgan Healthcare Con
Drug Sector on a High as 9 Drugmakers Strike Drug Pricing Deals
09:31am, Monday, 22'nd Dec 2025
Amgen and eight other pharma giants struck deals with the Trump administration to cut U.S. drug prices while gaining tariff relief and manufacturing incentives.
FOSTER CITY, Calif. & SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) and Assembly Biosciences, Inc. (Nasdaq: ASMB), today announced Gilead has exercised its combine
Trump Secures Drug Price Cuts From 9 Major Pharma Firms Including Bristol Myers, Gilead, Merck In Medicaid Deal
01:38am, Saturday, 20'th Dec 2025
Trump and nine major pharmaceutical companies struck deals to lower drug prices for cash payers and Medicaid, with over $150 billion pledged for U.S. R&D and manufacturing.
Market Today: Oracle-TikTok JV, Tesla Pay Reinstated, Nike Sinks
05:35pm, Friday, 19'th Dec 2025
Guru Stock PicksVanguard Health Care Fund has made the following transactions:Reduce in ARGX by 14.38%Sold out in PACSAdd in CLDX by 3.64%New position in PTGXCI
Trump strikes deal with US drugmakers to cut Medicaid medicine costs
03:14pm, Friday, 19'th Dec 2025
Officials pledge ‘massive savings' as companies agree to offer drugs at prices paid in other wealthy countries
Nine of the largest pharma companies ink deals with Trump to lower drug prices
02:34pm, Friday, 19'th Dec 2025
Several of the largest U.S. and European-based drugmakers inked deals with President Donald Trump to voluntarily sell their medications for less, as his administration pushes to link the nation's drug
Gilead and U.S. Government Enter Agreement to Lower Costs of Medicines for Americans
02:21pm, Friday, 19'th Dec 2025
FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced an agreement with the U.S. government designed to reduce drug costs for Americans, reinforcing the company's
Trump to announce new drug-pricing deals later today
10:45am, Friday, 19'th Dec 2025
The White House is getting ready to announce more deals with drugmakers aimed at lowering drug prices.
